☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands | 001-40466 | 98-1574360 | ||
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||
Unit 1101, 11th Floor 1 Lyndhurst Tower 1 Lyndhurst Terrace Central, Hong Kong | ||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Class A ordinary shares, par value $0.0001 per share | SMIH | The Nasdaq Stock Market LLC | ||
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | SMIHW | The Nasdaq Stock Market LLC | ||
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant | SMIHU | The Nasdaq Stock Market LLC |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Page | ||||
1 | ||||
2 | ||||
3 | ||||
19 | ||||
September 30, 2021 (unaudited) | December 31, 2020 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash | $ | 1,075,137 | $ | — | ||||
Prepaid expenses | 221,704 | — | ||||||
Total current assets | 1,296,841 | — | ||||||
Deferred offering costs | 91,374 | |||||||
Investments held in Trust Account | 200,003,049 | — | ||||||
Total Assets | $ | 201,299,890 | $ | 91,374 | ||||
Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ Equity | ||||||||
Current liabilities: | ||||||||
Accrued offering costs and expenses | $ | 72,619 | $ | 65,000 | ||||
Due to related party | 37,667 | — | ||||||
Note payable – related party | — | 5,010 | ||||||
Total current liabilities | 110,286 | 70,010 | ||||||
FPA liability | 2,807,021 | — | ||||||
Warrant liability | 13,800,974 | — | ||||||
Deferred underwriting commissions -- | 7,000,000 | — | ||||||
Total Liabilities | 23,718,281 | 70,010 | ||||||
Commitments and Contingencies (Note 8) | 0 | 0 | ||||||
Class A ordinary shares, $0.0001 par value; 20,000,000 shares and -0- | 200,000,000 | — | ||||||
Shareholders’ (Deficit) Equity: | ||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; 0ne issued and outstanding | 0— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; | 0 | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 and 6,500,000 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively | 575 | 650 | (1) | |||||
Additional paid-in capital | — | 24,350 | ||||||
Accumulated deficit | (22,418,966 | ) | (3,636 | ) | ||||
Total shareholders’ (Deficit) Equity | (22,418,391 | ) | 21,364 | |||||
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ (Deficit) Equity | $ | 201,299,890 | $ | 91,374 | ||||
March 31, 2022 | December 31, 2021 | |||||||
(unaudited) | ||||||||
Assets | ||||||||
Current assets: | ||||||||
Cash | $ | 720,222 | $ | 885,198 | ||||
Prepaid expenses | 63,428 | 141,677 | ||||||
Total current assets | 783,650 | 1,026,875 | ||||||
Investments held in Trust Account | 200,027,415 | 200,007,275 | ||||||
Total Assets | $ | 200,811,065 | $ | 201,034,150 | ||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | ||||||||
Current liabilities: | ||||||||
Accrued offering costs and expenses | $ | 133,110 | $ | 142,631 | ||||
Total current liabilities | 133,110 | 142,631 | ||||||
FPA liability | 2,658,312 | 2,785,941 | ||||||
Warrant liability | 3,210,656 | 10,423,429 | ||||||
Deferred underwriting commissions | 7,000,000 | 7,000,000 | ||||||
Total Liabilities | 13,002,078 | 20,352,001 | ||||||
Commitments and Contingencies (Note 7) | 0 | 0 | ||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 20,000,000 shares issued and outstanding at redemption value of $10.00 per share, at March 31, 2022 and December 31, 2021 | 200,000,000 | 200,000,000 | ||||||
Shareholders’ Deficit | ||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; 0ne issued or outstanding | 0— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 20,000,000 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively | 0 | 0 | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively | 575 | 575 | ||||||
Accumulated deficit | (12,191,588 | ) | (19,318,426 | ) | ||||
Total shareholders’ Deficit | (12,191,013 | ) | (19,317,851 | ) | ||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | $ | 200,811,065 | $ | 201,034,150 | ||||
For the Three Months Ended September 30, 2021 | For the Nine Months Ended September 30, 2021 | |||||||
General and administrative expenses | $ | 202,904 | $ | 246,868 | ||||
Loss from operations | (202,904 | ) | (246,868 | ) | ||||
Other income (expense): | ||||||||
Change in fair value of FPA | (561,983 | ) | (2,807,021 | ) | ||||
Change in fair value of warrant liability | 1,797,111 | (88,010 | ) | |||||
Transaction costs allocable to warrants | 0 | (507,417 | ) | |||||
Interest earned on investments held in Trust Account | 2,573 | 3,049 | ||||||
Other income (loss) | 1,237,701 | (3,399,399 | ) | |||||
Net income (Loss) | $ | 1,034,797 | $ | (3,646,267 | ) | |||
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption | 20,000,000 | 8,205,128 | ||||||
Basic and diluted net income (loss) per ordinary share, Class A ordinary shares subject to possible redemption | $ | 0.04 | $ | (0.26 | ) | |||
Basic and diluted weighted average shares outstanding, Class B non-redeemable ordinary shares | 5,750,000 | 5,750,000 | ||||||
Basic and diluted net income (loss) per share, Class B non-redeemable ordinary shares | $ | 0.04 | $ | (0.26 | ) | |||
For the Three Months ended March 31, 2022 | For the Three Months ended March 31, 2021 | |||||||
General and administrative expenses | $ | 233,704 | $ | 0 | ||||
Loss from operations | (233,704 | ) | 0 | |||||
Other income: | ||||||||
Change in fair value of FPA | 127,629 | 0 | ||||||
Change in fair value of warrant liability | 7,212,773 | 0 | ||||||
Interest earned on investments held in Trust Account | 20,140 | 0 | ||||||
Other income | 7,360,542 | — | ||||||
Net Income | $ | 7,126,838 | $ | 0 | ||||
Basic and diluted weighted average shares outstanding, Class A ordinary shares | 20,000,000 | 0 | ||||||
Basic and diluted net income per ordinary share, Class A ordinary shares | $ | 0.28 | $ | 0 | ||||
Basic and diluted weighted average shares outstanding, Class B ordinary shares | 5,750,000 | 5,750,000 | ||||||
Basic and diluted net income per share, Class B ordinary shares | $ | 0.28 | $ | 0 | ||||
Class A Ordinary Shares | Class B Ordinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total Shareholders’ (Deficit) Equity | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||
Balance as of December 31, 2020 (audited) | 0 | $ | 0 | 6,500,000 | $ | 650 | $ | 24,350 | $ | (3,636 | ) | $ | 21,364 | |||||||||||||||
Excess of private placement proceed over fair value as capital contribution | — | — | — | — | 798,445 | — | 798,445 | |||||||||||||||||||||
Accretion of Class A ordinary shares to redemptio n value | — | — | — | — | (822,795 | ) | (18,769,138 | ) | (19,591,933 | ) | ||||||||||||||||||
Net loss | — | — | — | — | — | (4,681,064 | ) | (4,681,064 | ) | |||||||||||||||||||
Balance as of June 30, 2021 (unaudited) | 0 | $ | 0 | 6,500,000 | $ | 650 | $ | 0 | $ | (23,453,838 | ) | $ | (23,453,188 | ) | ||||||||||||||
Forfeiture of founder shares | — | — | (750,000 | ) | (75 | ) | — | 75 | — | |||||||||||||||||||
Net income | — | — | — | — | — | 1,034,797 | 1,034,797 | |||||||||||||||||||||
Balance as of September 30, 2021 (unaudited) | 0 | 0 | 5,750,000 | 575 | 0 | (22,418,966 | ) | (22,418,391 | ) | |||||||||||||||||||
Class A Ordinary Shares | Class B Ordinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total Shareholders’ (Deficit) Equity | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||
Balance as of December 31, 2021 | 0 | $ | 0 | 5,750,000 | $ | 575 | $ | 0 | $ | (19,318,426 | ) | $ | (19,317,851 | ) | ||||||||||||||
Net income | — | — | — | — | — | 7,126,838 | 7,126,838 | |||||||||||||||||||||
Balance as of March 31, 2022 | 0 | $ | 0 | 5,750,000 | $ | 575 | $ | 0 | $ | (12,191,588 | ) | $ | (12,191,013 | ) | ||||||||||||||
Class A Ordinary Shares | Class B Ordinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total Shareholders’ (Deficit) Equity | ||||||||||||||||||||||||
Shares | Amount | Shares (1) | Amount | |||||||||||||||||||||||||
Balance as of December 31, 2020 | 0 | $ | 0 | 6,500,000 | $ | 650 | $ | 24,350 | $ | (3,636 | ) | $ | 21,364 | |||||||||||||||
Net loss | — | — | — | — | — | 0 | 0 | |||||||||||||||||||||
Balance as of March 31, 2021 | 0 | $ | 0 | 6,500,000 | $ | 650 | $ | 24,350 | $ | (3,636 | ) | $ | 21,364 | |||||||||||||||
(1) | This number includes up to 750,000 Class B ordinary shares subject to forfeiture as of March 31, 2021. On July 23, 2021, the 750,000 Class B ordinary shares were forfeited when the overallotment option expired. |
Cash Flows from Operating Activities: | ||||
Net loss | $ | (3,646,267 | ) | |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
Interest earned on investments held in Trust Account | (3,049 | ) | ||
Change in fair value of FPA liability | 2,807,021 | |||
Change in fair value of warrant liability | 88,010 | |||
Transaction costs allocable to warrants | 507,417 | |||
Changes in operating assets and liabilities: | ||||
Prepaid expenses | (221,704 | ) | ||
Accrued offering costs and expenses | 7,619 | |||
Due to related party | 37,667 | |||
Net cash used in operating activities | (423,286 | ) | ||
Cash Flows from Investing Activities | ||||
Investment of cash in Trust Account | (200,000,000 | ) | ||
Net cash used in investing activities | (200,000,000 | ) | ||
Cash Flows from Financing Activities: | ||||
Proceeds received from initial public offering, net of underwriters’ discount | 196,000,000 | |||
Proceeds from private placement | 6,000,000 | |||
Payment of offering costs | (140,554 | ) | ||
Repayment of note payable from related party | (361,023 | ) | ||
Net cash provided by financing activities | 201,498,423 | |||
Net change in cash | 1,075,137 | |||
Cash, beginning of the period | 0 | |||
Cash, end of the period | $ | 1,075,137 | ||
Supplemental Non-cash disclosure of cash flow information: | ||||
Deferred offering costs paid by Sponsor under promissory note | $ | 135,544 | ||
Deferred underwriting commissions | $ | 7,000,000 | ||
For the Three Months ended March 31, 2022 | For the Three Months ended March 31, 2021 | |||||||
Cash Flows from Operating Activities: | ||||||||
Net income | $ | 7,126,838 | $ | 0 | ||||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
Interest earned on investments held in Trust Account | (20,140 | ) | 0 | |||||
Change in fair value of FPA liability | (127,629 | ) | — | |||||
Change in fair value of warrant liability | (7,212,773 | ) | — | |||||
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses | 78,249 | — | ||||||
Accrued offering costs and expenses | (9,521 | ) | — | |||||
Net cash used in operating activities | (164,976 | ) | — | |||||
Net change in cash | (164,976 | ) | 0 | |||||
Cash, beginning of the period | 885,198 | 0 | ||||||
Cash, end of the period | $ | 720,222 | $ | 0 | ||||
Supplemental disclosure of non-cash investing and financing activity | ||||||||
Deferred offering costs paid by Sponsor under promissory note | $ | 0 | $ | 35,000 | ||||
Accrued deferred offering costs | $ | 0 | $ | 115,632 |
As Previously Reported | Adjustments | As Restated | ||||||||||
Balance Sheet at June 11, 2021 | ||||||||||||
Class A ordinary shares, $0.0001par value; subject to possible redemption at $10.00 per share | $ | 173,394,700 | $ | 26,605,300 | $ | 200,000,000 | ||||||
Class A ordinary shares - $0.0001 par value | 266 | (266 | ) | 0 | ||||||||
Additional paid-in capital | 7,835,896 | (7,835,896 | ) | 0 | ||||||||
Accumulated deficit | $ | (2,836,811 | ) | $ | (18,769,138 | ) | $ | (21,605,949 | ) | |||
Total shareholders’ equity | 5,000,001 | (26,605,300 | ) | (21,605,299 | ) | |||||||
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ (Deficit) Equity | 202,189,233 | 0 | 202,189,233 | |||||||||
Number of shares subject to redemption | 17,339,470 | 2,660,530 | 20,000,000 | |||||||||
Balance Sheet at June 30, 2021 (unaudited) | ||||||||||||
Class A ordinary shares, $0.0001par value; subject to possible redemption at $10.00 per share | $ | 171,546,810 | $ | 28,453,190 | $ | 200,000,000 | ||||||
Class A ordinary shares - $0.0001 par value | 285 | (285 | ) | 0 | ||||||||
Additional paid-in capital | 9,683,767 | (9,683,767 | ) | 0 | ||||||||
Accumulated deficit | $ | (4,684,700 | ) | $ | (18,769,138 | ) | $ | (23,453,838 | ) | |||
Total shareholders’ equity (deficit) | 5,000,002 | (28,453,190 | ) | (23,453,188 | ) | |||||||
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ (Deficit) Equity | 202,173,211 | 0 | 202,173,211 | |||||||||
Number of shares subject to redemption | 17,154,681 | 2,845,319 | 20,000,000 | |||||||||
Statement of Operations for the three months ended June 30, 2021 | ||||||||||||
Basic and diluted weighted average shares outstanding of Class A, ordinary shares subject to redemption | 20,000,000 | (15,604,396 | ) | 4,395,604 | ||||||||
Basic and diluted net income (loss) per share of Class A, ordinary shares subject to redemption | $ | 0.00 | $ | (0.46 | ) | $ | (0.46 | ) | ||||
Basic and diluted weighted average shares outstanding of Class B, non-redeemable ordinary shares | 5,750,000 | — | 5,750,000 | |||||||||
Basic and diluted net loss per share of Class B, non-redeemable ordinary shares | $ | (0.81 | ) | $ | 0.35 | $ | (0.46 | ) | ||||
Statement of Operations for the six months ended June 30, 2021 | ||||||||||||
Basic and diluted weighted average shares outstanding of Class A, ordinary shares subject to redemption | $ | 20,000,000 | $ | (17,790,055 | ) | $ | 2,209,945 | |||||
Basic and diluted net income (loss) per share of Class A, ordinary shares subject to redemption | $ | — | $ | (0.59 | ) | $ | (0.59 | ) | ||||
Basic and diluted weighted average shares outstanding of Class B, non-redeemable ordinary shares | 5,750,000 | — | 5,750,000 | |||||||||
Basic and diluted net loss per share of Class B, non-redeemable ordinary shares | (0.81 | ) | 0.22 | (0.59 | ) | |||||||
Statement of Cash Flows for the six months ended June 30, 2021 | ||||||||||||
Initial value of Class A common stock subject to possible redemption | 173,394,700 | 26,605,300 | 200,000,000 | |||||||||
Change in value of Class A common stock subject to possible redemption | (1,847,890 | ) | 1,847,890 | 0 |
Gross proceeds | $ | 200,000,000 | $ | 200,000,000 | ||||
Less: Proceeds allocated to Public Warrants | (8,511,409 | ) | (8,511,409 | ) | ||||
Less: Class A ordinary shares issuance costs | (11,080,524 | ) | (11,080,524 | ) | ||||
Add: Accretion of carrying value to redemption value | 19,591,933 | 19,591,933 | ||||||
Class A ordinary shares subject to possible redemption | $ | 200,000,000 | $ | 200,000,000 | ||||
For the Three Months Ended September 30, 2021 | For the Nine Months ended September 30, 2021 | For the Three Months Ended March 31, 2022 | For the Three Months Ended March 31, 2021 | |||||||||||||||||||||||||||||
Class A | Class B | Class A | Class B | Class A | Class B | Class A | Class B | |||||||||||||||||||||||||
Basic and diluted net income per share: | ||||||||||||||||||||||||||||||||
Numerator: | ||||||||||||||||||||||||||||||||
Allocation of net income (loss) | $ | 803,726 | $ | 231,071 | $ | (2,143,878 | ) | $ | (1,502,389 | ) | ||||||||||||||||||||||
Allocation of net income | $ | 5,560,451 | $ | 1,598,630 | $ | 0 | $ | 0 | ||||||||||||||||||||||||
Denominator: | ||||||||||||||||||||||||||||||||
Weighted-average shares outstanding | 20,000,000 | 5,750,000 | 8,205,128 | 5,750,000 | 20,000,000 | 5,750,000 | 0 | 5,750,000 | ||||||||||||||||||||||||
Basic and diluted net income (loss) per share | $ | 0.04 | $ | 0.04 | $ | (0.26 | ) | $ | (0.26 | ) | ||||||||||||||||||||||
Basic and diluted net income per share | $ | 0.28 | $ | 0.28 | $ | 0 | $ | 0 | ||||||||||||||||||||||||
(Level 1) | (Level 2) | (Level 3) | ||||||||||
Assets | ||||||||||||
Investments held in Trust Account | $ | 200,027,415 | $ | — | $ | — | ||||||
Liabilities | ||||||||||||
Public Warrants | $ | 2,001,000 | $ | 0 | $ | 0 | ||||||
Private Warrants | $ | — | $ | — | $ | 1,209,656 | ||||||
FPA liability | $ | — | $ | — | $ | 2,658,312 |
(Level 1) | (Level 2) | (Level 3) | ||||||||||
Assets | ||||||||||||
Investments held in Trust Account | $ | 200,007,275 | $ | — | $ | — | ||||||
Liabilities | ||||||||||||
Public Warrants | $ | 6,500,000 | $ | — | $ | — | ||||||
Private Warrants | $ | — | $ | — | $ | 3,923,429 | ||||||
FPA liability | $ | — | $ | — | $ | 2,785,941 |
(Level 1) | (Level 2) | (Level 3) | ||||||||||
Investments held in Trust Account | $ | 200,003,049 | $ | — | $ | — | ||||||
Liabilities | ||||||||||||
Public Warrants | $ | 8,601,000 | $ | — | $ | 0 | ||||||
Private Warrants | $ | — | $ | — | $ | 5,199,974 | ||||||
FPA liability | $ | — | $ | — | $ | 2,807,021 |
Input | June 11, 2021 | September 30, 2021 | March 31, 2022 | December 31, 2021 | ||||||||||||
Volatility | 16.30 | % | 17.8 | % | 4.00 | % | 13.4 | % | ||||||||
Risk Free Rate | 0.89 | % | 1.04 | % | 2.41 | % | 1.29 | % | ||||||||
Stock Price | $ | 9.5746 | 9.7500 | $ | 9.71 | $ | 9.72 | |||||||||
Est. Term Remaining (Yrs) | 5.65 | 5.35 | 5.65 | 5.35 |
Warrant liabilities | ||||
Fair value at December 31, 2021 | $ | 3,923,429 | ||
Change in fair value | (2,713,773 | ) | ||
Fair Value at March 31, 2022 | $ | 1,209,656 |
Derivative warrant liabilities | ||||
Fair value at January 1, 2021 | $ | 0 | ||
Initial value at IPO date | 13,712,964 | |||
Change in fair value | 88,010 | |||
Transfer of Public warrants from level 3 to level 1 | (8,601,000 | ) | ||
Fair Value at September 30, 2021 | $ | 5,199,974 |
Input | June 11, 2021 | September 30, 2021 | ||||||
Volatility | 16.30 | % | 17.8 | % | ||||
Stock Price | $ | 9.5746 | 9.7500 | |||||
Warrant Price | $ | 0.851 | 0.860 | |||||
Est. Term to Business Combination (Yrs) | 0.65 | 0.35 | ||||||
Probability of Business Combination | 85 | % | 85 | % | ||||
Purchase price of FPA unit | $ | 10.00 | 10.00 |
Input | March 31, 2022 | December 31, 2021 | ||||||
Volatility | 4.00 | % | 13.4 | % | ||||
Stock Price | $ | 9.71 | $ | 9.72 | ||||
Warrant Price | $ | 0.20 | $ | 0.65 | ||||
Est. Term to Business Combination (Yrs) | 0.65 | 0.33 | ||||||
Probability of Business Combination | 85 | % | 85 | % | ||||
Purchase price of FPA unit | $ | 10.00 | $ | 10.00 |
FPA liability | ||||
Fair value at December 31, 2021 | $ | 2,785,941 | ||
Change in fair value | 335,571 | |||
Fair Value at March 31, 2022 | $ | 2,658,312 |
FPA liability | ||||
Fair value at January 1, 2021 | $ | 0 | ||
Initial value at IPO date | 2,322,741 | |||
Change in fair value | 484,280 | |||
Fair Value at September 30, 2021 | $ | 2,807,021 |
Item 2. |
Item 3. |
Item 4. |
Item 1. |
Item 1A. | Risk Factors. |
Item 2. |
Item 3. |
Item 4. |
Item 5. |
Item 6. |
Number | ||
31.2* | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1** | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101.INS* | Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
* | Filed herewith. |
** | Furnished. |
SUMMIT HEALTHCARE ACQUISITION CORP. | ||||
By: | /s/ Bo Tan | |||
Name: | Bo Tan |
Title: | Chief Executive Officer, |
Co-Chief Investment |
Officer and Director |
(Principal Executive Officer and Principal |
Financial and Accounting Officer) |